Casodex (bicalutamide)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Casodex (bicalutamide), covering 2015-08-19 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients [Phase 2]